Today before the opening bell, Galena Biopharma announced that its President and Chief Executive Officer will be presenting a corporate update at the Rodman & Renshaw Annual Global Investment Conference. The company’s presentation will take place on Monday, September 9, 2013, at 10:25 a.m. ET at the Millennium Broadway Hotel in New York, NY.
Galena Biopharma is focused on developing and commercializing targeted oncology treatments to address major unmet medical needs and advance cancer care. The company’s peptide vaccine immunotherapies harness the patient’s own immune system to identify and destroy cancer cells. Utilizing peptide immunogens has many clinical advantages, including an excellent safety profile and long-lasting protection through immune system activation and convenient delivery.
For more information on Galena, visit www.galenabiopharma.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
No comments:
Post a Comment